The newly formed French biotech company OSE Immunotherapeutics SA is to accelerate the development of products in its R&D pipeline that include an immunologic, Tedopi , in Phase III for poor-progno
IN VITRO DIAGNOSTICS Mergers & Acquisitions DNA Diagnostics Center MTS Health Investors sold DNA Diagnostics Center (DDC) to London-based GHO Capital for $110mm (€104mm). (Oct.) Through the acquis